Lightstone Ventures was founded in 2012 by the General Partners and other key members of the life science teams of Advanced Technology Ventures (ATV) and Morgenthaler.  The firm was formed to capture the upside of investing in breakthrough life science companies during a time of unique opportunity in the space.

A Decade of Investing

Members of the Lightstone team have worked together on numerous new life science enterprises over the last decade.  We have similar styles and strategies and have demonstrated success and staying power with our legacy portfolio companies through market ups and downs.  Members of the Lightstone team manage a portfolio of more than 50 medical device and biotechnology companies across the ATV and Morgenthaler legacy funds (Legacy Funds).

A Clear Directive

We believe the time is now to energize the venture and healthcare industries by creating a premier therapeutic-oriented life science venture fund.  With strategic insight and a proven strategy, we are well-positioned to continue to find unique investments and drive life science innovations to patients.

Steady, Proven Track Record

By joining forces, we have created a whole that is greater than the sum of our individual successes.  Members of the Lightstone team have been involved in several of the largest, venture-backed life science exits over the last decade including: Ardian, Avidia, Caremedic, Ensure, FoldRx, Forsight Vision2, Hypnion, IPC, Ironwood, IVS, MicroVention, Morphotek, Orexigen, Perclose, Plexxikon, Proteolix, Solta, Threshold, and TranS1.